| Product Name | APOBEC3A antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to APOBEC3A (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A)This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. This gene encodes a protein that lacks the zinc binding activity and may be an expressed pseudogene. [provided by RefSeq] |
| Immunogen | Recombinant protein encompassing a sequence within the center region of human APOBEC3A. The exact sequence is proprietary. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| *Optimal dilutions/concentrations should be determined by the researcher. | |
| Predicted Reactivity | Human, Rhesus MonkeyHuman (100%), Rhesus Monkey (82%) |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Affinity purified |
| Gene Synonyms | ARP3 antibody, PHRBN antibody, bK150C2.1 antibody, APOBEC3A antibody, probable DNA dC->dU-editing enzyme APOBEC-3A antibody, phorbolin 1 antibody, phorbolin-1 antibody, "apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A antibody" |
|---|---|
| Molecular Weight(MW) | 23 kDa (note) |
| Positive Control | Target recombinant protein |
|---|---|
| Application Notes | *Optimal dilutions/concentrations should be determined by the researcher. |
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | 1XPBS, 1% BSA, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative. |
